NEW YORK ( TheStreet) -- CHANGE IN RATINGSBest Buy ( BBY) upgraded at Goldman to Buy from Neutral on product cycle recovery. Price target inflated to $47 from $44. 2010 and 2011 EPS estimates increased to $3.33 and $3.53, respectively. Cintas ( CTAS) downgraded at Barclays to Underweight from Equal Weight as fundamentals do not justify valuation. 2010 and 2011 EPS estimate set at $1.46 and $1.50, respectively. Maintain $21 price target. DirecTV ( DTV) downgraded at Citi to Hold from Buy as most good news is priced in. Maintain $38 target. 2010 and 2011 EPS estimates set at $2.27 and $3.20, respectively. F5 Networks ( FFIV) downgraded at BofA/Merrill from Buy to Neutral. Valuation call, based on a $65 price target. Humana ( HUM) downgraded at Argus from Buy to Hold. $46 price target. Company could lose Tricare contract and see changes in Medicare funding. ITT ( ITT) downgraded at BofA/Merrill from Buy to Underperform. $58 price target. Estimates also lowered, as the company has relatively less cyclical earnings leverage. Palm ( PALM) price target cut at Barclays to $4.50 from $7 as inventory overhand is a major challenge. 2010 and 2011 EPS estimates sunk to -$1.49 and -$1.15, respectively. Equal Weight rating. Palm ( PALM) downgraded at Kaufman PALM was downgraded from Hold to Sell. $3 price target. Company may not be profitable for the next 4-6 quarters, and will likely have to raise more capital. Synaptics ( SYNA) downgraded at Oppenheimer from Outperform to Perform. Channel checks suggest that the mobile business is struggling. Integrys Energy Group ( TEG) downgraded at Citi to Sell from Hold on valuation. Price target raised to $42 from $40. 2010 EPS estimate cut to $2.98, 2011 increased to $3.20.
STOCK COMMENTS / EPS CHANGESAgilent Technologies ( A) numbers boosted at Credit Suisse. Price target lifted to $40 from $36 as the close of VARI acquisition is imminent, Credit Suisse said. 2010 and 2011 EPS estimates raised to $1.75 and $2.28, respectively. Maintain Outperform rating. Boston Scientific ( BSX) estimates lowered at BofA/Merrill through 2011. ICD recall will hurt profits. Neutral rating and $10 price target.
CVS Caremark ( CVS) estimates cut at Credit Suisse. CVS 2010 and 2011 EPS estimates lowered to $2.74 and $3.07, respectively. Reiterate Outperform rating and $37 price target. FedEx ( FDX) numbers raised at Goldman FDX price target increased to $102 from $95 after a strong 4Q10. Estimates raised through 2012. Maintain Neutral rating. FedEx ( FDX) target, estimates boosted at Barclays. Price target increased to $106 from $98. 2010 and 2011 EPS estimates raised to $3.71 and $5.20, respectively. Reiterate Overweight rating. Jabil Circuits ( JBL) numbers boosted at RBC. Shares of JBL now seen reaching $22. Estimates also raised, as the company should be able to grow its margins in the near term. Limited Brands ( LTD) target, estimates raised at Barclays. LTD shares now seen reaching $33, up from $26. Barclays noted strong cash flow. 2010 and 2011 EPS estimates lifted to $1.63 and $2.00, respectively. Overweight rating. Sunpower ( SPWRA) price target cut at Citi. SPWRA price target lowered to $15 from $18. Maintain Sell rating. 2010 and 2011 EPS estimates increased to $1.16 and $1.56, respectively. Sunpower ( SPWRA) estimates, target lowered at FBR. Shares of SPWRA now seen reaching $22. Estimates also cut, as the company is realizing lower margins. Market Perform rating. Sempra Energy ( SRE) price target lower at Goldman. SRE price target cut to $52 from $55 as full JV sale presents downside risk to EPS. Estimates lowered through 2012. Neutral rating. STR Holdings ( STRI) price target boosted at Goldman to $17 from $15 on higher volume and revenue growth anticipated in 1H10. 2010 and 2011 EPS estimates set at 73 cents and 83 cents, respectively. Maintain Neutral rating. Triquint Semiconductor ( TQNT) target, estimates higher at Barclays. Price target raised by a dollar to $9 after positive analyst day. Maintain Overweight rating. 2010 and 2011 EPS estimates improved to 60 cents and 70 cents, respectively. Walgreen ( WAG) estimate lower at Credit Suisse. WAG 2010 EPS estimate fell by 2 cents to $2.23, 2011 set at $2.70. Near-term outlook is challenging. Maintain Outperform rating and $42 price target. WNS Holdings ( WNS) target, estimates lowered at Goldman. WNS price target sunk to $14.50 from $16.50 on lower revenue growth into 2011. Neutral rating. Estimates lowered through 2012.